Jerzy Hildebrand
- Genetics top 0.5%
- Neurology top 1%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Co-authors
- Serge GoldmanMarc LevivierJean‐Yves DelattreJacques BrotchiJ.‐Y. DelattreBenoît PirotteSophie TaillibertAndré Luxen
- Topics
- Glioma Diagnosis and Treatment (41 papers)Brain Metastases and Treatment (21 papers)Cancer Treatment and Pharmacology (15 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Jerzy Hildebrand
116 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 116
- Genetics 1.3k
- Neurology 847
- Pulmonary and Respiratory Medicine 832
- Oncology 803
- Radiology, Nuclear Medicine and Imaging 689
Countries citing papers authored by Jerzy Hildebrand
This map shows the geographic impact of Jerzy Hildebrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy Hildebrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy Hildebrand more than expected).
Fields of papers citing papers by Jerzy Hildebrand
This network shows the impact of papers produced by Jerzy Hildebrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy Hildebrand. The network helps show where Jerzy Hildebrand may publish in the future.
Co-authorship network of co-authors of Jerzy Hildebrand
This figure shows the co-authorship network connecting the top 25 collaborators of Jerzy Hildebrand. A scholar is included among the top collaborators of Jerzy Hildebrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerzy Hildebrand. Jerzy Hildebrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 68 | |
| 2 | 15 | |
| 3 | 20 | |
| 4 | 129 | |
| 5 | Stroke due to artery dissection: Role of collagen disease | 3 |
| 6 | 9 | |
| 7 | 32 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 29 | |
| 11 | 17 | |
| 12 | 53 | |
| 13 | 1 | |
| 14 | 63 | |
| 15 | 1 | |
| 16 | 15 | |
| 17 | 6 | |
| 18 | 6 | |
| 19 | Effect of ritanserin, a selective serotonin-S2 antagonist, on parkinsonian rest tremor | 17 |
| 20 | 12 |
About Jerzy Hildebrand
Jerzy Hildebrand is a scholar working on Genetics, Neurology and Cellular and Molecular Neuroscience, having authored 120 papers that have together received 3.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (41 papers), Brain Metastases and Treatment (21 papers) and Cancer Treatment and Pharmacology (15 papers). The work is most often cited by research in Genetics (1.3k citations), Neurology (847 citations) and Radiology, Nuclear Medicine and Imaging (689 citations). Jerzy Hildebrand has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Serge Goldman, Marc Levivier, Jean‐Yves Delattre, Jacques Brotchi, J.‐Y. Delattre, Benoît Pirotte, Sophie Taillibert, André Luxen, Khê Hoang‐Xuan and Sophie Dethy. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.